Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dynorphin A modulates acute and chronic opioid effects

L P Hooke1, L He, N M Lee

  • 1Department of Pharmacology, University of Minnesota Medical School, Minneapolis, USA.

The Journal of Pharmacology and Experimental Therapeutics
|April 1, 1995
PubMed
Summary

Dynorphin A-(1-13) [dyn A(1-13)] and its non-opioid analog dyn A(2-17) effectively suppress opioid withdrawal and tolerance in mice. Repeated dosing of dyn A(1-13) significantly enhanced these effects, demonstrating dose-dependent efficacy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term efficacy and safety of self-intracavernous injection of prostaglandin E1 for treatment of erectile dysfunction in China.

Andrologia·2011
Same author

Determination of the platelet activating factor in silicotic patients and its effect on fibroblasts.

Environmental health and preventive medicine·2011
Same author

Evaluation of supporting role of a foldable capsular vitreous body with magnetic resonance imaging in the treatment of severe retinal detachment in human eyes.

Eye (London, England)·2011
Same author

A chronic pain: inflammation-dependent chemoreceptor adaptation in rat carotid body.

Respiratory physiology & neurobiology·2011
Same author

Dissemination of IncFII plasmids carrying rmtB and qepA in Escherichia coli from pigs, farm workers and the environment.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2011
Same author

Suitable reference gene selection for different strains and developmental stages of the carmine spider mite, Tetranychus cinnabarinus, using quantitative real-time PCR.

Journal of insect science (Online)·2011

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Opioid dependence is characterized by withdrawal symptoms and tolerance development.
  • Dynorphin peptides play complex roles in opioid systems.
  • Investigating non-opioid modulators offers novel therapeutic avenues.

Purpose of the Study:

  • To evaluate the efficacy of dynorphin A-(1-13) [dyn A(1-13)] and its analog dyn A(2-17) in suppressing opioid withdrawal and tolerance.
  • To investigate the dose-dependent and time-dependent effects of dyn A(1-13).
  • To confirm the non-opioid mechanism of action for these modulatory effects.

Main Methods:

  • Morphine-dependent mice were used to assess opioid withdrawal and tolerance.
  • Dyn A(1-13) and dyn A(2-17) were administered at various doses and regimens.

Related Experiment Videos

  • Naloxone was used to precipitate withdrawal jumping, and ED50 was calculated.
  • Effects were compared between single and repeated dosing protocols.
  • Main Results:

    • A single dose of dyn A(1-13) suppressed opioid withdrawal and tolerance.
    • The non-opioid peptide dyn A(2-17) demonstrated comparable efficacy to dyn A(1-13).
    • Repeated daily administration of dyn A(1-13) enhanced its suppressive effects in a dose-dependent manner, with maximal effect observed at 8.4 mumol/kg, increasing naloxone ED50 nearly 6-fold.

    Conclusions:

    • Dyn A(1-13) is effective in mitigating opioid withdrawal and tolerance.
    • The non-opioid analog dyn A(2-17) retains significant modulatory activity.
    • Repeated dosing strategies can potentiate the therapeutic effects of dyn A(1-13), highlighting its potential as a non-addictive therapeutic agent for opioid dependence.